Semaglutide binds to GLP-1 receptors in the pancreas, brain, and gastrointestinal tract, triggering a cascade of effects: Enhanced glucose-dependent insulin secretion Reduced glucagon output Delayed gastric emptying Direct appetite suppression through hypothalamic pathways Its no wonder why it became the darling of the weight loss world
Both had similar starting points
Long said he knew people, even before the campaign, who used Ozempic and it's "had a profound impact on their lives." Both actors agree that it's been a great opportunity to share clear information in a fun way that cuts through the crowded information landscape

When administered, these medications work through several mechanisms: Slowing gastric emptying - Food remains in the stomach longer, which can contribute to feelings of fullness Reducing appetite signaling - The medications act on brain regions involved in hunger and satiety Improving insulin secretion - In response to food intake, insulin release becomes more efficient, which is why these medications were originally developed for diabetes Decreasing glucagon secretion - This hormone raises blood sugar, so reducing it helps with glucose control The two primary GLP-1 receptor agonists used for weight loss are: Semaglutide - FDA-approved for weight management under the brand name Wegovy (also sold as Ozempic for diabetes and Rybelsus as an oral diabetes medication)